Skip to content
Trial Eligibility
Menu

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT06947993

This study is recruiting at 24 US sites in 13 states, according to its ClinicalTrials.gov record last updated .

Summary

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Atopic Dermatitis

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 100 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Novartis Pharmaceuticals
Last updated on ClinicalTrials.gov
September 28, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 2

  • Novartis Investigative Site · Birmingham, AL
  • Novartis Investigative Site · Birmingham, AL

Arkansas · 1

  • Novartis Investigative Site · Fort Smith, AR

California · 5

  • Novartis Investigative Site · Fountain Valley, CA
  • Novartis Investigative Site · Los Angeles, CA
  • Novartis Investigative Site · Sacramento, CA
  • Novartis Investigative Site · Santa Ana, CA
  • Novartis Investigative Site · Santa Monica, CA

District of Columbia · 1

  • Novartis Investigative Site · Washington D.C., DC

Florida · 2

  • Novartis Investigative Site · Miami, FL
  • Novartis Investigative Site · St. Petersburg, FL

Georgia · 2

  • Novartis Investigative Site · Atlanta, GA
  • Novartis Investigative Site · Macon, GA

Kentucky · 1

  • Novartis Investigative Site · Louisville, KY

Massachusetts · 1

  • Novartis Investigative Site · Brighton, MA

Michigan · 1

  • Novartis Investigative Site · Troy, MI

Missouri · 1

  • Novartis Investigative Site · Saint Joseph, MO

New Hampshire · 1

  • Novartis Investigative Site · Portsmouth, NH

New York · 1

  • Novartis Investigative Site · Brooklyn, NY

Texas · 5

  • Novartis Investigative Site · Arlington, TX
  • Novartis Investigative Site · Cypress, TX
  • Novartis Investigative Site · Dallas, TX
  • Novartis Investigative Site · Houston, TX
  • Novartis Investigative Site · San Antonio, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.